Results 81 to 90 of about 29,100 (168)

The Efficacy of Lacosamide in the Treatment of Delirium Complicated With Ileus: Four Cases

Neuropsychopharmacology Reports, Volume 46, Issue 1, March 2026.
Delirium in elderly patients is difficult to treat when complicated by ileus. This report describes three cases of antipsychotic‐induced paralytic ileus successfully managed with lacosamide without severe adverse effects. Lacosamide's pharmacological profile suggests it may be a safe treatment option for delirium tremens in older patients.
Shinji Sato
wiley   +1 more source

Catatonia an Unexpected Side Effect of Electroconvulsive Therapy: A Case Report

Neuropsychopharmacology Reports, Volume 46, Issue 1, March 2026.
This case report highlights an unexpected development of catatonia following electroconvulsive therapy in a patient with schizoaffective disorder. The catatonia resolved promptly after discontinuing psychotropic interventions, emphasizing the need for careful monitoring during ECT, especially in patients with complex psychiatric histories.
Fatemeh sheikhmoonesi, Behnam Abbasi, Tahoura Sedighi Barforoushi, Ebrahim Khoshnama   +3 more
wiley   +1 more source

Valbenazine induced acute parkinsonism in a patient with alcohol use disorder and central pontine myelinolysis

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 1, March 2026.
Abstract Background Valbenazine is used to treat dyskinesia and is generally associated with limited side effects; however, a few cases with the adverse effect of parkinsonism are reported in the literature. In this study, we report a case of valbenazine‐induced acute parkinsonism.
Yasuhito Nagai, Miyata Mamiko, Koichi Miyakawa   +2 more
wiley   +1 more source

Risperidone ISM: review and update of its usefulness in all phases of schizophrenia

Therapeutic Advances in Psychopharmacology
One of the most important challenges in the management of patients with schizophrenia is to ensure adherence to antipsychotic treatment. The contribution of long-acting injectables (LAI) is undeniable in this matter, but there are still some unmet ...
Thomas Messer, Miquel Bernardo, Lourdes Anta, Javier Martínez-González   +3 more
doaj   +1 more source

Use of monthly extended-release risperidone injection in schizophrenia: clinical experience

European Psychiatry
Introduction Monthly extended-release injectable risperidone is the new antipsychotic formulation of risperidone available in doses of 75 mg and 100 mg, approved for the treatment of schizophrenia.
E. de la Fuente Ruiz, M. D. C. Blasco Fresco, C. Álvarez Sanagustín, L. T. Durán Sandoval   +3 more
doaj   +1 more source

Asenapine for delirium in patients with cancer: A scoping review

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 1, March 2026.
Abstract This scoping review mapped the existing literature on the application of asenapine for delirium management in patients with cancer, including prevention and treatment, while summarizing current research trends. The review followed the methodological framework proposed by Arksey and O'Malley and was reported in accordance with the Preferred ...
Tetsuro Ishida, Makoto Kobayakawa, Jun Kako, Yoshinobu Matsuda, Ryoichi Sadahiro, Hitoshi Tanimukai   +5 more
wiley   +1 more source

Postictal psychosis concealed during long‐term video‐electroencephalographic monitoring and unmasked after discharge: A case report

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 1, March 2026.
Abstract Background Postictal psychosis (PIP) is a serious complication that can follow seizure clusters, including those provoked during long‐term video‐electroencephalographic monitoring (LTVEM). Early detection and appropriate treatment of PIP are crucial to implement LTVEM safely.
Shotaro Fujiwara, Takuto Ishida, Ryotaro Higuchi, Ayumu Kocha, Yo Muraoka, Yuki Nagashima, Hiroki Kocha, Atsuo Nakagawa, Yoshiyo Oguchi   +8 more
wiley   +1 more source

Real‐World Pharmacological Management of Alcohol Dependence in a Nepalese Rehabilitation Center: Prospective Cohort Study

Public Health Challenges, Volume 5, Issue 1, March 2026.
This prospective cohort study demonstrates that structured, evidence‐informed pharmacological management significantly reduced alcohol withdrawal severity and improved liver enzyme profiles among alcohol dependence patients in a Nepalese rehabilitation center, supporting the implementation of standardized treatment protocols in resource‐limited ...
Sanjay Singh, Nirmal Raj Marasine, Sabina Sankhi, Kabita Bhandari, Gajendra Bahadur Bhuju   +4 more
wiley   +1 more source

Managing High‐Risk Drug Interactions With Nirmatrelvir/Ritonavir: Experience From a Dedicated Pharmacology Advice Service

Clinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT Nirmatrelvir boosted with ritonavir is a key antiviral against COVID‐19, yet ritonavir's potent CYP3A4 inhibition exposes patients to numerous drug–drug interactions. To make prescribing safer, a national proactive system providing expert pharmacology advice was implemented in France.
Youssef Libiad, Bénédicte Franck, Camille Tron, Sébastien Lalanne, Christelle Boglione‐Kerrien, Fabrice Taïeb, Marie‐Clémence Verdier, Florian Lemaitre   +7 more
wiley   +1 more source

Impact of CYP2D6 Genotype and Inhibitor Use on Risperidone Metabolism in Children: Functional Insights Into the *17 and *29 Alleles

Clinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT Risperidone, an atypical antipsychotic, is increasingly prescribed in pediatric patients with psychiatric disorders. It is primarily metabolized by CYP2D6 to 9‐hydroxyrisperidone, an active metabolite associated with a higher risk of adverse effects.
Matthew H. Bennett, Ethan A. Poweleit, Samuel E. Vaughn, Brandon Retke, Paul Toren, Jeffrey R. Strawn, Laura B. Ramsey   +6 more
wiley   +1 more source